Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max R O'Donnell

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
TB/HIV: an orphan disease?James C M Brust, Max R O'Donnell, John Z Metcalfe
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 27, 2009
Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South AfricaMax R O'Donnell, N Padayatchi, I Master, et al.
Journal of Public Health Policy|May 31, 2013
Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV settingJennifer R Zelnick, Andrew Gibbs, Marian Loveday, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Reply to Kuindersma and Spronk: Time to Tailor the One-Size-Fits-All Approach?David M Furfaro, Pratik Sinha, Carolyn S Calfee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2019
Spatiotemporal Clustering of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Is Associated With Human Immunodeficiency Virus Status and Drug-Susceptibility Patterns in KwaZulu-Natal, South AfricaAllison Wolf, Nesri Padayatchi, Kogieleum Naidoo, et al.
Emerging Infectious Diseases|April 30, 2013
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infectionMax R O'Donnell, Nesri Padayatchi, Charlotte Kvasnovsky, et al.
Infection Control and Hospital Epidemiology|June 22, 2021
Evaluation of screening strategies for pulmonary tuberculosis among hospitalized patients in a low-burden setting: cost-effectiveness of GeneXpert MTB/RIF compared to smear microscopyAndrew J Hickey, Matthew J Cummings, Zafar Zafari, et al.
Emerging Infectious Diseases|October 18, 2011
Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South AfricaMax R O'Donnell, Jennifer Zelnick, Lise Werner, et al.
Respiratory Care|May 23, 2023
Approach to the Physiologically Challenging Endotracheal Intubation in the Intensive Care UnitAndrew J Hickey, Matthew J Cummings, Briana Short, et al.
The Lancet. HIV|March 9, 2019
Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infectionMax R O'Donnell, Nesri Padayatchi, Amrita Daftary, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
TB/HIV: an orphan disease?James C M Brust, Max R O'Donnell, John Z Metcalfe
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|June 27, 2009
Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South AfricaMax R O'Donnell, N Padayatchi, I Master, et al.
Journal of Public Health Policy|May 31, 2013
Health-care workers' perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV settingJennifer R Zelnick, Andrew Gibbs, Marian Loveday, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Reply to Kuindersma and Spronk: Time to Tailor the One-Size-Fits-All Approach?David M Furfaro, Pratik Sinha, Carolyn S Calfee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 21, 2019
Spatiotemporal Clustering of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Is Associated With Human Immunodeficiency Virus Status and Drug-Susceptibility Patterns in KwaZulu-Natal, South AfricaAllison Wolf, Nesri Padayatchi, Kogieleum Naidoo, et al.
Emerging Infectious Diseases|April 30, 2013
Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infectionMax R O'Donnell, Nesri Padayatchi, Charlotte Kvasnovsky, et al.
Infection Control and Hospital Epidemiology|June 22, 2021
Evaluation of screening strategies for pulmonary tuberculosis among hospitalized patients in a low-burden setting: cost-effectiveness of GeneXpert MTB/RIF compared to smear microscopyAndrew J Hickey, Matthew J Cummings, Zafar Zafari, et al.
Emerging Infectious Diseases|October 18, 2011
Extensively drug-resistant tuberculosis in women, KwaZulu-Natal, South AfricaMax R O'Donnell, Jennifer Zelnick, Lise Werner, et al.
Respiratory Care|May 23, 2023
Approach to the Physiologically Challenging Endotracheal Intubation in the Intensive Care UnitAndrew J Hickey, Matthew J Cummings, Briana Short, et al.
The Lancet. HIV|March 9, 2019
Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infectionMax R O'Donnell, Nesri Padayatchi, Amrita Daftary, et al.
Pageof 8